-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
ADC Therapeutics SA quarterly/annual Revenues history and growth rate from 2022 to 2023.
- ADC Therapeutics SA Revenues for the quarter ending September 30, 2024 was $18.5M, a 27.4% increase year-over-year.
- ADC Therapeutics SA Revenues for the twelve months ending September 30, 2024 was $70.7M.
- ADC Therapeutics SA annual Revenues for 2023 was $69.6M, a 66.9% decline from 2022.